Literature DB >> 27207683

Report on Ten Years' Experience of Premarital Hemoglobinopathy Screening at a Center in Antalya, Southern Turkey.

Duran Canatan1, Serpil Delibas1.   

Abstract

Thalassemia and hemoglobinopathies are a major public health problem in Turkey. Hemoglobinopathy prevention programs (HPPs) were started in 33 provinces situated in Thrace, Marmara, Aegean, Mediterranean and South Eastern regions of Turkey in 2003. A premarital hemoglobinopathy test is mandatory and free of charge in this program. According to the Ministry of Health reports, 46 first level hemoglobinopathy diagnostic centers were established for premarital tests. Within the last 10 years, approximately 79.0% of married individuals per year were screened by the centers. While the percentage of premarital screening tests was 30.0% of all couples in 2003, it reached 86.0% in 2013. The number of newborn with thalassemia and hemoglobinopathies were 272 in 2002 and dropped to 25 in 2013. There has been a 90.0% reduction in affected births. Our hemoglobinopathy diagnostic center was established in 2003 and licensed by the Ministry of Health in 2004. We studied a total of 89,981 blood samples from premarital tests for 10 years and the incidence of β- and α-thalassemia (β- and α-thal) trait was found to be 6.57 and 3.56%, respectively. The distribution of the most common abnormal hemoglobins (Hbs) was: Hb S (HBB: c.20A > T) (0.31%), Hb D-Los Angeles (HBB: c.364G > C) (0.15%), Hb G-Coushatta (HBB: c.68A > C) (0.06%) and Hb E (HBB: c.79G > A) (0.02%). A total of 60 couples, both carrying β-thal trait, were directed to the prenatal diagnosis (PND) center in 10 years. The premarital hemoglobinopathy screening program is running successfully at our center and other centers in Turkey.

Entities:  

Keywords:  Hemoglobinopathy; premarital screening; prevention

Mesh:

Substances:

Year:  2016        PMID: 27207683     DOI: 10.3109/03630269.2016.1170030

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Importance of DNA Sequencing for Abnormal Hemoglobins Detected by HPLC Screening

Authors:  Duran Canatan; Abdullah Çim; Serpil Delibaş; Emel Altunsoy; Serdar Ceylaner
Journal:  Turk J Haematol       Date:  2020-03-04       Impact factor: 1.831

Review 2.  Changing patterns in the epidemiology of β-thalassemia.

Authors:  Antonis Kattamis; Gian Luca Forni; Yesim Aydinok; Vip Viprakasit
Journal:  Eur J Haematol       Date:  2020-09-21       Impact factor: 2.997

3.  Factors Affecting the Willingness to Undertake Premarital Screening Test Among Prospective Marital Individuals.

Authors:  Ali Alkalbani; Maryam Alharrasi; Susan Achura; Ammar Al Badi; Amjad Al Rumhi; Khalid Alqassabi; Raya Almamari; Omar Alomari
Journal:  SAGE Open Nurs       Date:  2022-02-25

4.  A Novel Technique of Spectral Discrimination of Variants of Sickle Cell Anemia.

Authors:  Vadivel Masilamani; Sandanasamy Devanesan; Fatma AlQathani; Mashael AlShebly; Hebatullah Hassan Daban; Duran Canatan; Karim Farhat; Mansour Jabry; Mohamad S AlSalhi
Journal:  Dis Markers       Date:  2018-08-27       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.